- Home
- SYRE vs NFJ Comparison
SYRE vs NFJ Comparison
Compare SYRE & NFJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- NFJ
- Stock Information
- Founded
- SYRE 2013
- NFJ 2005
- Country
- SYRE United States
- NFJ United States
- Employees
- SYRE N/A
- NFJ N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- NFJ Finance: Consumer Services
- Sector
- SYRE Health Care
- NFJ Finance
- Exchange
- SYRE Nasdaq
- NFJ Nasdaq
- Market Cap
- SYRE 1.1B
- NFJ 1.2B
- IPO Year
- SYRE 2016
- NFJ N/A
- Fundamental
- Price
- SYRE $15.86
- NFJ $12.92
- Analyst Decision
- SYRE Buy
- NFJ
- Analyst Count
- SYRE 5
- NFJ 0
- Target Price
- SYRE $55.00
- NFJ N/A
- AVG Volume (30 Days)
- SYRE 414.7K
- NFJ 223.5K
- Earning Date
- SYRE 11-06-2025
- NFJ 01-01-0001
- Dividend Yield
- SYRE N/A
- NFJ 9.01%
- EPS Growth
- SYRE N/A
- NFJ N/A
- EPS
- SYRE N/A
- NFJ N/A
- Revenue
- SYRE N/A
- NFJ N/A
- Revenue This Year
- SYRE N/A
- NFJ N/A
- Revenue Next Year
- SYRE N/A
- NFJ N/A
- P/E Ratio
- SYRE N/A
- NFJ N/A
- Revenue Growth
- SYRE N/A
- NFJ N/A
- 52 Week Low
- SYRE $10.91
- NFJ $10.45
- 52 Week High
- SYRE $40.26
- NFJ $12.86
- Technical
- Relative Strength Index (RSI)
- SYRE 42.99
- NFJ 50.12
- Support Level
- SYRE $15.80
- NFJ $12.95
- Resistance Level
- SYRE $17.58
- NFJ $13.25
- Average True Range (ATR)
- SYRE 0.74
- NFJ 0.12
- MACD
- SYRE -0.11
- NFJ -0.01
- Stochastic Oscillator
- SYRE 9.78
- NFJ 17.07
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About NFJ Virtus Dividend Interest & Premium Strategy Fund of Beneficial Interest
Virtus Dividend, Interest & Premium Strategy Fund is a Massachusetts-based business trust. The primary investment objective of the company is to seek current income and gains, with a secondary objective of long-term capital appreciation. The fund pursues its investment objectives by investing in a diversified portfolio of dividend-paying common stocks and income-producing convertible securities.